HeadlinesBriefing favicon HeadlinesBriefing

Sector Investment 3 Days

×
8 articles summarized · Last updated: LATEST

Last updated: August 6, 2026, 5:30 PM ET

Infrastructure Fundraises and Personnel Moves

KKR has achieved a final close for its latest flagship infrastructure fund, gathering $19.2bn. This fund represents KKR's largest fundraising effort to date, surpassing the $17bn raised for its predecessor fund in March 2022. ECP has closed its largest fund on $8.1bn, with chief investment officer Tyler Reeder highlighting the fund's significant distributions to paid-in capital (DPI) as a key factor in its success. ECP VI closed more than 50% above its target in just 18 months. Agallas Equities is planning an inaugural infrastructure fund focused on the Caribbean, targeting $5bn for major projects in the Dominican Republic and surrounding areas. The fund has already garnered early interest from family offices in Gulf states.

Pension Fund Dynamics and Asset Class Perceptions

APG has seen its longstanding Asia-Pacific infrastructure head depart after 25 years with the €639bn Dutch pension manager. This departure follows that of its global infrastructure head just a month prior. Danish pension fund Industriens Pension, with €37bn in assets, continues its approach to infrastructure investing, co-investments, and secondaries despite current geopolitical turbulence, according to head of infrastructure Mikkel Kjaersgaard. Aware Super is in discussions to merge with Prime Super, a move that would add Prime Super's approximately A$8bn in assets under management to Aware Super's substantial capital pool. The combined entity would manage well over A$250bn. Questions remain regarding the perception of certain infrastructure assets, such as transport packaging, with market participants considering whether limited partners will accept these investments as part of a diversified portfolio.

Healthcare and Life Sciences Transactions

Altaris has announced its intention to acquire the Life Sciences & Healthcare business from Clarivate. This strategic acquisition is expected to reshape a segment of the healthcare and life sciences private equity landscape.